Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-20-023990

Options or other derivatives

  • Chief Financial Officer acquired 152,052 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Regnante Keith · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-04-07 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +18,430 18,430 D
2020-04-07 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +133,622 133,622 D
Loading xslF345X03/doc4.xml…